In the airways of those with cystic fibrosis (CF), the leading pathophysiological hypothesis is that an ion channel defect results in a relative decrease in airway surface liquid (ASL) volume, producing thick and sticky mucus that facilitates the establishment and progression of early fatal lung disease. This hypothesis predicts that any successful CF airway treatment for this fundamental channel defect should increase the ASL volume, but up until now there has been no method of measuring this volume that would be compatible with in vivo monitoring. In order to accurately monitor the volume of the ASL, we have developed a new x-ray phase contrast imaging method that utilizes a highly attenuating reference grid. In this study we used this imaging method to examine the effect of a current clinical CF treatment, aerosolized hypertonic saline, on ASL depth in ex vivo normal mouse tracheas, as the first step towards non-invasive in vivo ASL imaging. The ex vivo tracheas were treated with hypertonic saline, isotonic saline or no treatment using a nebuliser integrated within a small animal ventilator circuit. Those tracheas exposed to hypertonic saline showed a transient increase in the ASL depth, which continued for nine minutes post-treatment, before returning to baseline by twelve minutes. These findings are consistent with existing measurements on epithelial cell cultures, and therefore suggest promise for the future development of in vivo testing of treatments. Our grid-based imaging technique measures the ASL depth with micron resolution, and can directly observe the effect of treatments expected to increase ASL depth, prior to any changes in overall lung health. The ability to non-invasively observe micron changes in the airway surface, particularly if achieved in an in vivo setting, may have potential in pre-clinical research designed to bring new treatments for CF and other airway diseases to clinical trials.
References
[1]
Boucher RC (2004) New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J 23: 146–158.
[2]
Knowles MR, Boucher RC (2002) Mucus Clearance as a primate inate defense mechanism for mammalian airways. J Clin Invest 109: 571–577.
[3]
Matsui H, Grubb BR, Tarran R, Randell SH, Gatzy JT, et al. (1998) Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 95: 1005–1015.
[4]
Boucher RC (2007) Evidence for airway surface dehydration as the initiating event in CF airway disease. J Intern Med 261: 5–16.
[5]
Ratjen R, Grasemann H (2012) New Therapies in Cystic Fibrosis. Current Pharmaceutical Design 18: 614–627.
[6]
Daviskas E, Anderson SD, Gonda I, Eberl S, Meikle S, et al. (1996) Inhalation of hypertonic saline aerosol enhances mucociliary clearance in asthmatic and healthy subjects. ERJ 9: 725–732.
[7]
Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty RN, et al. (2006) A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 354: 229–240.
[8]
Donaldson S, Bennett W, Zeman K, Knowles MR, Tarran R, et al. (2006) Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med 354: 250.
[9]
Griesenbach U, Boyd AC (2005) Pre-clinical and clinical endpoint assays for cystic fibrosis gene therapy. J Cyst Fibros 4: 89–100.
[10]
Ramsey BW, Davies J, McElvaney NG, Tullis E, Bell SC, et al. (2011) A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 365: 1663–72.
[11]
Brody AS, Tiddens HAWM, Castile RG, Coxson HO, de Jong PA, et al. (2005) Computed Tomography in the Evaluation of Cystic Fibrosis Lung Disease. Am J Respir Crit Care Med 172: 1246–1252.
[12]
Tarran R, Button B, Picher M, Paradiso AM, Ribeiro CM, et al. (2005) Normal and cystic fibrosis airway surface liquid homeostasis. The effects of phasic shear stress and viral infections. J Biol Chem 280: 35751–35759.
[13]
Song Y, Namking W, Nieldson DW, Lee J-W, Finkbeiner WE, et al. (2009) Airway surface liquid depth measured in ex vivo fragments of pig and human trachea: dependence on Na+ and Cl- channel function. Am J Physiol Lung Cell Mol Physiol 297: L1131–L1140.
[14]
Morgan KS, Paganin DM, Siu KKW (2011) Quantitative single-exposure x-ray phase contrast imaging using a single attenuation grid. Opt Express 19: 19781–19789.
[15]
Morgan KS, Paganin DM, Parsons DW, Donnelley M, Yagi N, et al. (2012) Single grating x-ray imaging for dynamic biological systems. AIP Conf. Proc 1466: 124–129.
[16]
Cloetens P, Barrett R, Baruchel J, Guigay JP, Schlenker M (1996) Phase objects in synchrotron radiation hard x-ray imaging. J Phys D: App Phs 29: 133–146.
[17]
Snigirev A, Snigireva I, Kohn V, Kuznetsov S, Schelokov I (1995) On the possibilities of x-ray phase contrast microimaging by coherent high-energy synchrotron radiation. Rev Sci Instrum 66: 5486–5492.
[18]
Davis TJ, Gao D, Gureyev TE, Stevenson AW, Wilkins SW (1995) Phase-contrast imaging of weakly absorbing materials using hard x-rays. Nature 373: 595–598.
[19]
Momose A, Kawamoto S, Koyama I, Hamaishi Y, Takai K, et al. (2003) Demonstration of x-ray Talbot interferometry. Jpn J Appl Phys 42: L866–L868.
[20]
Pfeiffer F, Weitkamp T, Bunk O, David C (2006) Phase retrieval and differential phase-contrast imaging with low-brilliance x-ray sources. Nature Physics 2: 258–261.
[21]
Kitchen MJ, Lewis RA, Morgan MJ, Wallace MJ, Siew ML, et al. (2008) Dynamic Measures of Regional Lung Air Volume using Phase Contrast X-ray Imaging. Phys. Med. Biol 53 (21) 6065–6077.
[22]
Donnelley M, Siu K, Morgan K, Skinner W, Suzuki Y, et al. (2010) A new technique to examine individual pollutant particle and fibre deposition and transit behaviour in live mouse trachea. J Synch Radiat 17: 719–729.
[23]
Hartmann J (1900) “Bemerkungen über den Bau und die Justirung von Spektrographen”. Zt Instrumentenkd 29 (47)
[24]
Shack RV (1971) “Production and use of a lenticular Hartmann screen”. Journal of the Optical Society of America 61 (656)
[25]
Mayo SC, Sexton B (2004) Refractive microlens array for wavefront analysis in the medium to hard x-ray range. Opt Lett 29: 866–8.
[26]
Morgan KS, Paganin DM, Siu KKW (2012a) X-ray phase imaging with a paper analyzer. Appl Phys Lett 100: 124102.
[27]
Morgan KS, Paganin DM, Siu KKW (2011a) Quantitative x-ray phase-contrast imaging using a single grating of comparable pitch to sample feature size. Opt Lett 36: 55–57.
[28]
Tarran R, Grubb BR, Parsons D, Picher M, Hirsh AJ, et al. (2001) The CF salt controversy: in vivo observations and therapeutic approaches. Mol Cell 8: 149–158.
